ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Coronavirus vaccine: Chinese company preps late-stage trials in UAE

Sinopharm joins compatriots in phase three testing amid race to market

Chinese vaccine developers are conducting phase three trials overseas as coronavirus cases diminish domestically.   © Reuters

DALIAN, China -- Chinese drugmaker Sinopharm is preparing phase three clinical trials for a coronavirus vaccine candidate in the United Arab Emirates.

Sinopharm affiliate China National Biotec Group received approval from UAE health authorities to run the late-stage trials, the company said late Tuesday. The Middle Eastern country plans to host the vaccine's production if the study is completed successfully.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more